1. The slideshow contains the most important forecasts for a company's divisions, or product lines.
2. Disagree with a forecast? Simply drag the trend-line to test your own what-if scenario, and see possible upside or downside risks for a stock.
3. Plot data for competitors and benchmarks using the "Competition" button.
4. In the slide caption, and the area below the slideshow, see the key trends impacting a given forecast, as well as historical explanations.
5. The first slide shows which one of a company's divisions, or product lines, contribute most to its stock price. Clicking on a division arm of the diagram, you can explore the most important forecasts for the division.
Trefis has a team of in-house Analysts who gather historical data from company filings and other verifiable sources.
The data and sources are available on the Trefis website.
The Trefis team of in-house Analysts considers a variety of factors when projecting any forecast, and their rationale
is explained on the Trefis website.
1. We use forecasts for various business drivers to calculate forecasted Revenues and Profits for .
2. We then use forecasted Profits in a Discounted Cash Flow (DCF) model to obtain the Price Estimate for .
The Trefis forecasts are used to calculate future revenues, costs and cash profits for .
The future cash profits are then discounted to the present to arrive at the total value of .
The total value divided by number of shares outstanding is the Price estimate.
Trefis Analysts estimate a price of $124 for Abbott Labs' stock, about 8% higher than the current market price.
* Medical Devices constitute 45% of the Trefis price estimate for Abbott Labs's stock.
* Diagnostics constitute 25% of the Trefis price estimate for Abbott Labs's stock.
* Nutritionals constitute 19% of the Trefis price estimate for Abbott Labs's stock.
Less
Trefis Analysts estimate a price of $124 for Abbott Labs' stock, about 8% higher than the current market price.
* Medical Devices constitute 45% of the Trefis price estimate for Abbott Labs's stock.
* Diagnostics constitute 25% of the Trefis price estimate for Abbott Labs's stock.
* Nutritionals constitute 19% of the Trefis price estimate for Abbott Labs's stock.